MatthewBolandYurgelunMD

Clinical Fellow in Medicine, Beth Israel Deaconess Medical Center

Dr. Yurgelun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006

PubMed

103 citations
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Elena M. Stoffel, Shannon E. McKernin, Randall E. Brand, Marcia I. Canto, Michael Goggins
Journal of Clinical Oncology. 2019-01-10
48 citations
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.
Lipika Goyal, Hui Zheng, Thomas A. Abrams, Rebecca A. Miksad, Andrea J. Bullock
Clinical Cancer Research. 2019-01-01
55 citations
Combined PD-1, BRAF and MEK inhibition in BRAFcolorectal cancer: a phase 2 trial.
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis
Nature Medicine. 2023-02-01

Journal Articles

Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer
Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal Adenocarcinoma
Lynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature

Lectures

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
2019 ASCO Annual Meeting - 6/1/2019
Lynch Syndrome: Update on Comprehensive Screening and Risk Reduction.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Join now to see all

Starch Supplement Reduces the Risk of Some Hereditary CancersJuly 26th, 2022
Daily Aspirin Reduced CRC Risk in Lynch Syndrome PatientsJune 19th, 2020
Therapy-Associated Polyposis May Mimic Hereditary CRC Symptoms in AYA Cancer SurvivorsFebruary 20th, 2020
Join now to see all